SIGN UP
LOG IN
MARKET
NEO
NEO
Neogenomics Inc
NASDAQ
13.68
-0.17
-1.23%
Closed 18:19 04/17 EDT
OPEN
13.97
PREV CLOSE
13.85
HIGH
13.97
LOW
13.63
VOLUME
561.43K
TURNOVER
0
52 WEEK HIGH
21.22
52 WEEK LOW
11.03
MARKET CAP
1.75B
P/E (TTM)
-19.5178
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NEO last week (0408-0412)?
Weekly Report · 3d ago
Small and midcap pair trades for every sector - Oppenheimer
Oppenheimer's technical analysis team is out with more buy/sell pair trades for small and midcap stocks. Analyst Ari Wald recommends a buy and a sell based on charts for every sector. Energy Buy PBF Energy (PBF) and Materials Buy Hawkins (HWKN) 50/50 SMID portfolio picks 50 buys and 50 sells from Russell 2000 and S&P 400 Midcap.
Seeking Alpha · 3d ago
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 3d ago
25 GDP-sensitive Small-Cap stocks with low refinancing risk - BofA
25 GDP-sensitive Small-Cap stocks with low refinancing risk - BofA. Securities published the top 25 small-cap stocks that rank highly on GDP sensitivity and low on interest rates. Bof a analysts recommend investors focus on areas that can benefit from a GDP, commodity price, and manufacturing recovery.
Seeking Alpha · 5d ago
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
NASDAQ · 04/10 15:07
Press Release: NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024. Company management will host a webcast and conference call to discuss financial results and recent highlights. NeoGenomics is a leading oncology testing services company. The company specializes in cancer genetics testing and information services.
Dow Jones · 04/09 11:00
Weekly Report: what happened at NEO last week (0401-0405)?
Weekly Report · 04/08 11:16
Weekly Report: what happened at NEO last week (0325-0329)?
Weekly Report · 04/01 11:14
About NEO
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
Webull offers NeoGenomics, Inc. stock information, including NASDAQ: NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.